Greater Adherence to Cardioprotective Diet Can Reduce Inflammatory Bowel Disease Risk: A Longitudinal Cohort Study

Tian Fu1, Shuyu Ye1, Yuhao Sun2

  • 1Department of Gastroenterology, The Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha 410013, China.

Nutrients
|October 14, 2022
PubMed

Insights

A cardioprotective diet may lower the risk of developing inflammatory bowel disease (IBD). Greater adherence to this diet was linked to a reduced incidence of IBD, suggesting a potential preventative dietary strategy.

Area of Science:

  • Nutrition Science
  • Gastroenterology
  • Epidemiology

Background:

  • The cardioprotective diet's anti-inflammatory effects are known for cardiometabolic diseases.
  • The relationship between cardioprotective diets and inflammatory bowel disease (IBD) risk remains under-explored.

Purpose of the Study:

  • To investigate the association between adherence to a cardioprotective diet and the risk of developing IBD.

Main Methods:

  • A cardioprotective diet score was calculated using food frequency questionnaire data from the UK Biobank.
  • Incident IBD cases were identified through primary care, inpatient, and death registry data.
  • Cox proportional hazard models analyzed the association between diet score and IBD risk.

Main Results:

  • Over 12.1 years, 2717 incident IBD cases (851 Crohn's disease, 1866 ulcerative colitis) were recorded.
  • Higher cardioprotective diet scores (3, 4, and 5-7) were associated with a significantly decreased risk of IBD compared to scores of 0-1.
  • A significant inverse trend (p < 0.001) was observed between diet score and IBD risk.

Conclusions:

  • Increased adherence to a cardioprotective diet is associated with a lower risk of developing IBD.
  • Dietary modification towards a cardioprotective pattern may be a strategy for IBD prevention.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
395
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
349
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
172
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
20
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
296
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
17